Subtopic Deep Dive
Medication Adherence Interventions
Research Guide
What is Medication Adherence Interventions?
Medication Adherence Interventions are behavioral, technological, and educational strategies designed to improve patient compliance with prescribed medication regimens in chronic diseases such as hypertension and diabetes.
Researchers conduct meta-analyses and systematic reviews to evaluate intervention efficacy, long-term outcomes, and cost-effectiveness. Key papers include Cutler et al. (2018) with 849 citations on economic impacts and Gast and Mathes (2019) with 443 citations on influencing factors. Over 10 high-citation studies from 2005-2023 quantify non-adherence costs and intervention effects.
Why It Matters
Improving adherence via pharmacist roles reduces hospitalizations and healthcare costs, as shown in Nkansah et al. (2010) Cochrane review (332 citations) demonstrating better patient outcomes. Economic analyses by Cutler et al. (2018) estimate billions in annual losses from non-adherence across disease groups. Interventions like those in Demonceau et al. (2013) meta-analysis (315 citations) enhance electronically monitored dosing, supporting global chronic disease management in hypertension and diabetes.
Key Research Challenges
Heterogeneity in Intervention Effects
Interventions vary widely in design, leading to inconsistent outcomes across studies. Cross et al. (2020) Cochrane review (232 citations) found behavioral interventions improve adherence but effects differ by patient age and polypharmacy. Meta-analyses struggle with standardization (Demonceau et al., 2013).
Measuring True Adherence Levels
Self-reports overestimate adherence compared to electronic monitoring. Demonceau et al. (2013) systematic review (315 citations) assessed electronically compiled histories for accurate intervention evaluation. Challenges persist in validating measures for long-term studies (Gast and Mathes, 2019).
Economic and Scalability Barriers
High costs limit implementation despite proven benefits. Cutler et al. (2018) review (849 citations) quantified non-adherence costs by disease but noted scalability issues for technological interventions. Baryakova et al. (2023) highlighted drug delivery innovations needing cost-effectiveness data (353 citations).
Essential Papers
Economic impact of medication non-adherence by disease groups: a systematic review
Rachelle Louise Cutler, Fernando Fernández-Llimós, Michael Frommer et al. · 2018 · BMJ Open · 849 citations
Objective To determine the economic impact of medication non-adherence across multiple disease groups. Design Systematic review. Evidence review A comprehensive literature search was conducted in P...
Medication adherence influencing factors—an (updated) overview of systematic reviews
Alina Gast, Tim Mathes · 2019 · Systematic Reviews · 443 citations
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma
Ioana Agache, Jessica Beltrán, Cezmi A. Akdiş et al. · 2020 · Allergy · 379 citations
Abstract Five biologicals have been approved for severe eosinophilic asthma, a well‐recognized phenotype. Systematic reviews (SR) evaluated the efficacy and safety of benralizumab, dupilumab, mepol...
Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems
Tsvetelina Baryakova, Brett H. Pogostin, Róbert Langer et al. · 2023 · Nature Reviews Drug Discovery · 353 citations
Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns
Nancy Nkansah, Olga Mostovetsky, Christine Yu et al. · 2010 · Cochrane Database of Systematic Reviews · 332 citations
Only one included study compared pharmacist services with other health professional services, hence we are unable to draw conclusions regarding comparisons 1 and 3. Most included studies supported ...
Medication Therapy Management: 10 Years of Experience in a Large Integrated Health Care System
Djenane Ramalho de Oliveira, Amanda Brummel, David B. Miller · 2020 · Journal of Managed Care & Specialty Pharmacy · 318 citations
There was no external funding for this manuscript. The 3 authors are employees of Fairview Pharmacy Services. Ramalho de Oliveira had primary responsibility for the concept and design, writing, and...
Identification and Assessment of Adherence-Enhancing Interventions in Studies Assessing Medication Adherence Through Electronically Compiled Drug Dosing Histories: A Systematic Literature Review and Meta-Analysis
Jenny Demonceau, Todd Ruppar, Paulus Kristanto et al. · 2013 · Drugs · 315 citations
Reading Guide
Foundational Papers
Start with Nkansah et al. (2010, 332 citations) for pharmacist intervention evidence and Demonceau et al. (2013, 315 citations) for electronic monitoring protocols, as they establish core measurement and outcome baselines.
Recent Advances
Study Cutler et al. (2018, 849 citations) for economic quantification and Cross et al. (2020, 232 citations) for polypharmacy strategies in older adults.
Core Methods
Systematic reviews/meta-analyses (Cochrane methods in Nkansah et al., 2010; electronic dosing in Demonceau et al., 2013); behavioral/educational interventions (Cross et al., 2020); cost-effectiveness modeling (Cutler et al., 2018).
How PapersFlow Helps You Research Medication Adherence Interventions
Discover & Search
Research Agent uses searchPapers and exaSearch to find Cutler et al. (2018) on economic impacts, then citationGraph reveals 849 citing papers on cost-effectiveness, while findSimilarPapers identifies Gast and Mathes (2019) for adherence factors.
Analyze & Verify
Analysis Agent applies readPaperContent to extract intervention effects from Nkansah et al. (2010), uses verifyResponse (CoVe) for claim checking, and runPythonAnalysis with GRADE grading to meta-analyze adherence rates statistically from Demonceau et al. (2013) dosing data.
Synthesize & Write
Synthesis Agent detects gaps in polypharmacy interventions via Cross et al. (2020), flags contradictions between economic papers, and Writing Agent uses latexEditText, latexSyncCitations for Cutler et al., and latexCompile to generate review manuscripts with exportMermaid for intervention flowcharts.
Use Cases
"Run meta-analysis on adherence rates from electronic monitoring studies"
Research Agent → searchPapers('electronic dosing histories') → Analysis Agent → runPythonAnalysis(pandas meta-analysis on Demonceau et al. 2013 data) → GRADE graded summary statistics with confidence intervals.
"Draft Cochrane-style review on pharmacist interventions for adherence"
Synthesis Agent → gap detection (Nkansah et al. 2010) → Writing Agent → latexEditText(structure sections) → latexSyncCitations(10 papers) → latexCompile → PDF with adherence outcome tables.
"Find code for modeling non-adherence costs in diabetes"
Research Agent → paperExtractUrls(Cutler et al. 2018) → Code Discovery → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis(adapt cost model with NumPy for hypertension scenarios).
Automated Workflows
Deep Research workflow conducts systematic reviews by chaining searchPapers(50+ adherence papers) → citationGraph → DeepScan(7-step analysis with CoVe checkpoints on Nkansah et al.). Theorizer generates hypotheses on innovative delivery from Baryakova et al. (2023), synthesizing gaps into testable intervention models.
Frequently Asked Questions
What defines Medication Adherence Interventions?
Strategies including behavioral, technological, and educational methods to boost patient compliance in chronic diseases like hypertension and diabetes, evaluated via meta-analyses for outcomes and costs.
What are key methods in adherence interventions?
Pharmacist non-dispensing roles (Nkansah et al., 2010), electronic dosing monitoring (Demonceau et al., 2013), and behavioral interventions for older adults (Cross et al., 2020).
What are the most cited papers?
Cutler et al. (2018, 849 citations) on economic impacts; Gast and Mathes (2019, 443 citations) on factors; Nkansah et al. (2010, 332 citations) on pharmacist roles.
What are open problems in this subtopic?
Standardizing heterogeneous interventions, scaling cost-effective technologies (Baryakova et al., 2023), and improving long-term adherence measurement beyond electronic histories.
Research Pharmaceutical studies and practices with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching Medication Adherence Interventions with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.